Cargando…

Volatile molecules from bronchoalveolar lavage fluid can ‘rule-in’ Pseudomonas aeruginosa and ‘rule-out’ Staphylococcus aureus infections in cystic fibrosis patients

Respiratory infections caused by Pseudomonas aeruginosa and Staphylococcus aureus are the leading cause of morbidity and mortality in cystic fibrosis (CF) patients. The authors aimed to identify volatile biomarkers from bronchoalveolar lavage (BAL) samples that can guide breath biomarker development...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasir, Mavra, Bean, Heather D., Smolinska, Agnieszka, Rees, Christiaan A., Zemanick, Edith T., Hill, Jane E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770459/
https://www.ncbi.nlm.nih.gov/pubmed/29339749
http://dx.doi.org/10.1038/s41598-017-18491-8
_version_ 1783293074034655232
author Nasir, Mavra
Bean, Heather D.
Smolinska, Agnieszka
Rees, Christiaan A.
Zemanick, Edith T.
Hill, Jane E.
author_facet Nasir, Mavra
Bean, Heather D.
Smolinska, Agnieszka
Rees, Christiaan A.
Zemanick, Edith T.
Hill, Jane E.
author_sort Nasir, Mavra
collection PubMed
description Respiratory infections caused by Pseudomonas aeruginosa and Staphylococcus aureus are the leading cause of morbidity and mortality in cystic fibrosis (CF) patients. The authors aimed to identify volatile biomarkers from bronchoalveolar lavage (BAL) samples that can guide breath biomarker development for pathogen identification. BAL samples (n = 154) from CF patients were analyzed using two-dimensional gas chromatography time-of-flight mass spectrometry. Random Forest was used to select suites of volatiles for identifying P. aeruginosa-positive and S. aureus-positive samples using multiple infection scenarios and validated using test sets. Using nine volatile molecules, we differentiated P. aeruginosa-positive (n = 7) from P. aeruginosa-negative (n = 53) samples with an area under the receiver operating characteristic curve (AUROC) of 0.86 (95% CI 0.71–1.00) and with positive and negative predictive values of 0.67 (95% CI 0.38–0.75) and 0.92 (95% CI 0.88–1.00), respectively. We were also able to discriminate S. aureus-positive (n = 15) from S. aureus-negative (n = 45) samples with an AUROC of 0.88 (95% CI 0.79-1.00) using eight volatiles and with positive and negative predictive values of 0.86 (95% CI 0.61–0.96) and 0.70 (95% CI 0.61–0.75), respectively. Prospective validation of identified biomarkers as screening tools in patient breath may lead to clinical application.
format Online
Article
Text
id pubmed-5770459
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-57704592018-01-26 Volatile molecules from bronchoalveolar lavage fluid can ‘rule-in’ Pseudomonas aeruginosa and ‘rule-out’ Staphylococcus aureus infections in cystic fibrosis patients Nasir, Mavra Bean, Heather D. Smolinska, Agnieszka Rees, Christiaan A. Zemanick, Edith T. Hill, Jane E. Sci Rep Article Respiratory infections caused by Pseudomonas aeruginosa and Staphylococcus aureus are the leading cause of morbidity and mortality in cystic fibrosis (CF) patients. The authors aimed to identify volatile biomarkers from bronchoalveolar lavage (BAL) samples that can guide breath biomarker development for pathogen identification. BAL samples (n = 154) from CF patients were analyzed using two-dimensional gas chromatography time-of-flight mass spectrometry. Random Forest was used to select suites of volatiles for identifying P. aeruginosa-positive and S. aureus-positive samples using multiple infection scenarios and validated using test sets. Using nine volatile molecules, we differentiated P. aeruginosa-positive (n = 7) from P. aeruginosa-negative (n = 53) samples with an area under the receiver operating characteristic curve (AUROC) of 0.86 (95% CI 0.71–1.00) and with positive and negative predictive values of 0.67 (95% CI 0.38–0.75) and 0.92 (95% CI 0.88–1.00), respectively. We were also able to discriminate S. aureus-positive (n = 15) from S. aureus-negative (n = 45) samples with an AUROC of 0.88 (95% CI 0.79-1.00) using eight volatiles and with positive and negative predictive values of 0.86 (95% CI 0.61–0.96) and 0.70 (95% CI 0.61–0.75), respectively. Prospective validation of identified biomarkers as screening tools in patient breath may lead to clinical application. Nature Publishing Group UK 2018-01-16 /pmc/articles/PMC5770459/ /pubmed/29339749 http://dx.doi.org/10.1038/s41598-017-18491-8 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Nasir, Mavra
Bean, Heather D.
Smolinska, Agnieszka
Rees, Christiaan A.
Zemanick, Edith T.
Hill, Jane E.
Volatile molecules from bronchoalveolar lavage fluid can ‘rule-in’ Pseudomonas aeruginosa and ‘rule-out’ Staphylococcus aureus infections in cystic fibrosis patients
title Volatile molecules from bronchoalveolar lavage fluid can ‘rule-in’ Pseudomonas aeruginosa and ‘rule-out’ Staphylococcus aureus infections in cystic fibrosis patients
title_full Volatile molecules from bronchoalveolar lavage fluid can ‘rule-in’ Pseudomonas aeruginosa and ‘rule-out’ Staphylococcus aureus infections in cystic fibrosis patients
title_fullStr Volatile molecules from bronchoalveolar lavage fluid can ‘rule-in’ Pseudomonas aeruginosa and ‘rule-out’ Staphylococcus aureus infections in cystic fibrosis patients
title_full_unstemmed Volatile molecules from bronchoalveolar lavage fluid can ‘rule-in’ Pseudomonas aeruginosa and ‘rule-out’ Staphylococcus aureus infections in cystic fibrosis patients
title_short Volatile molecules from bronchoalveolar lavage fluid can ‘rule-in’ Pseudomonas aeruginosa and ‘rule-out’ Staphylococcus aureus infections in cystic fibrosis patients
title_sort volatile molecules from bronchoalveolar lavage fluid can ‘rule-in’ pseudomonas aeruginosa and ‘rule-out’ staphylococcus aureus infections in cystic fibrosis patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770459/
https://www.ncbi.nlm.nih.gov/pubmed/29339749
http://dx.doi.org/10.1038/s41598-017-18491-8
work_keys_str_mv AT nasirmavra volatilemoleculesfrombronchoalveolarlavagefluidcanruleinpseudomonasaeruginosaandruleoutstaphylococcusaureusinfectionsincysticfibrosispatients
AT beanheatherd volatilemoleculesfrombronchoalveolarlavagefluidcanruleinpseudomonasaeruginosaandruleoutstaphylococcusaureusinfectionsincysticfibrosispatients
AT smolinskaagnieszka volatilemoleculesfrombronchoalveolarlavagefluidcanruleinpseudomonasaeruginosaandruleoutstaphylococcusaureusinfectionsincysticfibrosispatients
AT reeschristiaana volatilemoleculesfrombronchoalveolarlavagefluidcanruleinpseudomonasaeruginosaandruleoutstaphylococcusaureusinfectionsincysticfibrosispatients
AT zemanickeditht volatilemoleculesfrombronchoalveolarlavagefluidcanruleinpseudomonasaeruginosaandruleoutstaphylococcusaureusinfectionsincysticfibrosispatients
AT hilljanee volatilemoleculesfrombronchoalveolarlavagefluidcanruleinpseudomonasaeruginosaandruleoutstaphylococcusaureusinfectionsincysticfibrosispatients